HHS and the Surgeon General issue a warning on children’s screen use. The FDA rejects Sydnexis’ SYD-101 — despite the STAR trial meeting its primary endpoint. Hoya’s MiYOSMART iQ posts some of the strongest myopia control data ever reported.
69 MMP | Myopia News Monthly - The Surgeon General Agrees With Us
Previous
Previous
70 MMP | 5 AI Marketing Moves Every Myopia Practice Should Make This Week
Next
Next